Pathophysiology of L-dopa-induced dyskinesias

Mov Disord. 1999:14 Suppl 1:4-8.

Authors

P J Bédard¹, P J Blanchet, D Lévesque, J J Soghomonian, R Grondin, M Morissette, M Goulet, F Calon, P Falardeau, B Gomez-Mancilla, J P Doucet, G S Robertson, T DiPaolo

Affiliation

¹ Centre de recherche du CHUQ, Pavillon CHUL, and Department of Medicine, Faculty of Medicine and Faculty of Pharmacy, Laval University, Quebec City, Canada.

PMID: 10493397

No abstract available

Publication types

Review

MeSH terms

Animals
Binding, Competitive
Corpus Striatum / metabolism
Corpus Striatum / physiopathology*
Dopamine / metabolism
Dopamine Agonists / adverse effects*
Dopamine Agonists / pharmacokinetics
Dyskinesia, Drug-Induced / etiology*
Dyskinesia, Drug-Induced / physiopathology*
Globus Pallidus / metabolism
Haplorhini
Humans
Levodopa / adverse effects*
Levodopa / pharmacokinetics
Neural Pathways / metabolism
Neural Pathways / physiopathology*
Neurons / metabolism
Protein Isoforms / metabolism
Proto-Oncogene Proteins c-fos / metabolism
Receptors, GABA / metabolism
Substantia Nigra / metabolism
Substantia Nigra / physiopathology*

Substances

Dopamine Agonists
Protein Isoforms
Proto-Oncogene Proteins c-fos
Receptors, GABA
Levodopa
Dopamine